Institutional Ownership Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX). We have compiled data on the 1,724 institutions that hold shares in the stock, with a total of 221 Million shares, which have been reported (via 13F filing form) to have a value of $88 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Capital World Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
26,810,702
shares
|
$10.9 Billion
1.99% of portfolio
|
Q3 2024
Added 0.38%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
23,159,634
shares
|
$9.39 Billion
0.2% of portfolio
|
Q3 2024
Added 0.8%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,312,244
shares
|
$8.64 Billion
0.23% of portfolio
|
Q2 2024
Reduced 2.95%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
11,816,249
shares
|
$4.79 Billion
0.23% of portfolio
|
Q3 2024
Added 0.77%
|
|
|
Capital Research Global Investors
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
9,002,205
shares
|
$3.65 Billion
0.9% of portfolio
|
Q3 2024
Added 5.42%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
7,372,767
shares
|
$2.99 Billion
1.19% of portfolio
|
Q3 2024
Added 2.1%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
6,928,587
shares
|
$2.81 Billion
0.26% of portfolio
|
Q3 2024
Added 4.98%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
5,935,888
shares
|
$2.41 Billion
0.23% of portfolio
|
Q3 2024
Reduced 6.16%
|
|
|
Jennison Associates LLC
|
Nov 08, 2024 Q3 2024 |
5,550,386
shares
|
$2.25 Billion
1.61% of portfolio
|
Q3 2024
Added 18.11%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,798,870
shares
|
$1.94 Billion
0.4% of portfolio
|
Q3 2024
Added 17.2%
|
|
|
Amundi
Paris, I0 |
Nov 13, 2024 Q3 2024 |
3,759,236
shares
|
$1.52 Billion
0.66% of portfolio
|
Q3 2024
Added 7.28%
|
|
|
Loomis Sayles & CO L P
|
Nov 13, 2024 Q3 2024 |
3,068,214
shares
|
$1.24 Billion
1.87% of portfolio
|
Q3 2024
Reduced 2.35%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
3,038,437
shares
|
$1.23 Billion
0.1% of portfolio
|
Q3 2024
Reduced 6.76%
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,905,705
shares
|
$1.18 Billion
0.42% of portfolio
|
Q3 2024
Added 5.82%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
2,608,957
shares
|
$1.06 Billion
0.1% of portfolio
|
Q3 2024
Added 1.42%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
2,516,831
shares
|
$1.02 Billion
0.62% of portfolio
|
Q3 2024
Added 4.14%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
2,441,468
shares
|
$989 Million
0.3% of portfolio
|
Q3 2024
Reduced 5.53%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
2,365,992
shares
|
$959 Million
0.18% of portfolio
|
Q3 2024
Reduced 6.63%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
2,303,797
shares
|
$934 Million
0.23% of portfolio
|
Q3 2024
Reduced 4.91%
|
|
|
Clearbridge Investments, LLC
New York, NY |
Nov 12, 2024 Q3 2024 |
1,972,055
shares
|
$799 Million
0.75% of portfolio
|
Q3 2024
Reduced 5.68%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
1,943,604
shares
|
$788 Million
0.18% of portfolio
|
Q3 2024
Added 7.81%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
1,871,810
shares
|
$759 Million
0.23% of portfolio
|
Q3 2024
Reduced 8.9%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,768,010
shares
|
$717 Million
0.09% of portfolio
|
Q3 2024
Reduced 20.06%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
1,631,493
shares
|
$661 Million
1.2% of portfolio
|
Q3 2024
Added 4.16%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
1,626,347
shares
|
$659 Million
0.15% of portfolio
|
Q3 2024
Added 1.27%
|